Home/ Supplements/ Niacin/ Crypto V2

Crypto V2

product on market Powder Bio Tech Nutra Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 56% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile includes L-Citrulline, Beta-Alanine, and Betaine, which have moderate to strong evidence for supporting athletic performance and endurance. Vitamin B3 and L-Taurine contribute to metabolic function and cellular health. Overall, these ingredients are well-studied for their roles in exercise physiology.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Crypto V2
Open Full PDF View on NIH DSLD →
Details

Label Data

9.45 Gram(s)
Serving Size
20
Servings
Other Combinations
Product Type
56%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

15 mg (94% DV)
1.1× RDA — within safe limits 196 studies (A:5, B:63)
2000 mg
Market median: 2000.0mg (275 products)
1750 mg
Market median: 1500.0mg (104 products) 21 studies (A:0, B:2)
1250 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
500 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
Within RDA (0.9× RDA) 38 studies (A:1, B:7)
Crypto X Energy
341 mg
Nootropics

Other Ingredients

Natural & Artificial flavors Sucralose Malic Acid Acesulfame Potassium Silicon Dioxide
Claims

Label Claims — Verification

Unverified Structure/Function
Info

Product Information

Formulation Notes

Focus No crash Big pump Energy

Preworkout

40/20 Servings

Additional Information

BTN

Metadata

Product Details

DSLD Entry Date2021-04-22
Product TypeOther Combinations
FormPowder
DSLD ID247444
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.